REN and congenital bilateral aplasia of vas deferens from CFTR mutation: However, traditional cardiovascular drugs like lipid-lowering agents and renin-angiotensin system blocking drugs have proven to be unsuccessful in retarding the progression of CAVD in clinical trials, indicating for seeking for a more pivotal mechanism in the pathological process of CAVD.